Literature DB >> 23418108

Colloidal HPMO nanoparticles: silica-etching chemistry tailoring, topological transformation, and nano-biomedical applications.

Yu Chen1, Pengfei Xu, Hangrong Chen, Yongsheng Li, Wenbo Bu, Zhu Shu, Yaping Li, Jiamin Zhang, Lingxia Zhang, Limin Pan, Xiangzhi Cui, Zile Hua, Jin Wang, Linlin Zhang, Jianlin Shi.   

Abstract

Hybridization produces the better: Colloidal hollow periodic mesoporous organosilica nanoparticles (HPMO NPs) with tunable compositions and highly hybridized nanostructures are successfully synthesized by a simple, easily scale-up but versatile silica-etching chemistry (alkaline or HF etching) for their applications in nano-fabrication and nano-medicine.
Copyright © 2013 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23418108     DOI： 10.1002/adma.201204685

Source DB:  PubMed          Journal:  Adv Mater        ISSN： 0935-9648            Impact factor:   30.849


  11 in total

1.  Acidity/Reducibility Dual-Responsive Hollow Mesoporous Organosilica Nanoplatforms for Tumor-Specific Self-Assembly and Synergistic Therapy.

Authors:  Wei Tang; Wenpei Fan; Zhantong Wang; Weizhong Zhang; Shiyi Zhou; Yijing Liu; Zhen Yang; Emily Shao; Guofeng Zhang; Orit Jacobson; Lingling Shan; Rui Tian; Siyuan Cheng; Lisen Lin; Yulun Dai; Zheyu Shen; Gang Niu; Jin Xie; Xiaoyuan Chen
Journal:  ACS Nano       Date:  2018-11-15       Impact factor: 15.881

Review 2.  Development of individualized anti-metastasis strategies by engineering nanomedicines.

Authors:  Qianjun He; Shengrong Guo; Zhiyong Qian; Xiaoyuan Chen
Journal:  Chem Soc Rev       Date:  2015-06-09       Impact factor: 54.564

3.  Generic synthesis of small-sized hollow mesoporous organosilica nanoparticles for oxygen-independent X-ray-activated synergistic therapy.

Authors:  Wenpei Fan; Nan Lu; Zheyu Shen; Wei Tang; Bo Shen; Zhaowen Cui; Lingling Shan; Zhen Yang; Zhantong Wang; Orit Jacobson; Zijian Zhou; Yijing Liu; Ping Hu; Weijing Yang; Jibin Song; Yang Zhang; Liwen Zhang; Niveen M Khashab; Maria A Aronova; Guangming Lu; Xiaoyuan Chen
Journal:  Nat Commun       Date:  2019-03-18       Impact factor: 14.919

4.  PEG-Coated Large Mesoporous Silicas as Smart Platform for Protein Delivery and Their Use in a Collagen-Based Formulation for 3D Printing.

Authors:  Federica Banche-Niclot; Giorgia Montalbano; Sonia Fiorilli; Chiara Vitale-Brovarone
Journal:  Int J Mol Sci       Date:  2021-02-09       Impact factor: 5.923

5.  BSA-Stabilized Mesoporous Organosilica Nanoparticles Reversed Chemotherapy Resistance of Anaplastic Thyroid Cancer by Increasing Drug Uptake and Reducing Cellular Efflux.

Authors:  Xiao Han; Xiaoquan Xu; Yuxia Tang; Feipeng Zhu; Ying Tian; Wei Liu; Doudou He; Guangming Lu; Yunfei Gu; Shouju Wang
Journal:  Front Mol Biosci       Date:  2020-12-03

Review 6.  Recent Progress on Asymmetric Carbon- and Silica-Based Nanomaterials: From Synthetic Strategies to Their Applications.

Authors:  Haitao Li; Liang Chen; Xiaomin Li; Daoguang Sun; Haijiao Zhang
Journal:  Nanomicro Lett       Date:  2022-01-17

7.  Synthesis of Porous Hollow Organosilica Particles with Tunable Shell Thickness.

Authors:  Mohammed A Al-Khafaji; Anikó Gaál; Bálint Jezsó; Judith Mihály; Dorota Bartczak; Heidi Goenaga-Infante; Zoltán Varga
Journal:  Nanomaterials (Basel)       Date:  2022-04-01       Impact factor: 5.076

8.  Emerging integrated nanoclay-facilitated drug delivery system for papillary thyroid cancer therapy.

Authors:  Yi Zhang; Mei Long; Peng Huang; Huaming Yang; Shi Chang; Yuehua Hu; Aidong Tang; Linfeng Mao
Journal:  Sci Rep       Date:  2016-09-12       Impact factor: 4.379

9.  Extra-Large Pore Mesoporous Silica Nanoparticles Enabling Co-Delivery of High Amounts of Protein Antigen and Toll-like Receptor 9 Agonist for Enhanced Cancer Vaccine Efficacy.

Authors:  Bong Geun Cha; Ji Hoon Jeong; Jaeyun Kim
Journal:  ACS Cent Sci       Date:  2018-03-28       Impact factor: 14.553

Review 10.  Advances in nanomedicine for cancer starvation therapy.

Authors:  Shuangjiang Yu; Zhaowei Chen; Xuan Zeng; Xuesi Chen; Zhen Gu
Journal:  Theranostics       Date:  2019-10-17       Impact factor: 11.556
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.